Taken together, our and others data suggest that AKT-dependent downregulation of SNAIL 1 and SNAIL 2 expression in ovarian cancer cells is not necessarily determined by their resistance to cisplatin but rather by their place of origin. The gene discussed is AKT1; the disease is ovarian carcinoma.